Salesforce slides as investors weigh AI monetization concerns and recent analyst downgrades

Salesforce (CRM) is down 3.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be continued investor skepticism that Salesforce’s AI push is translating into durable core growth quickly enough. Recent analyst downgrades highlighted weak field feedback on Agentforce, slower expected monetization, and pressure in legacy software lines, which likely kept sellers active even after the company posted solid quarterly results earlier this year.

Details:

Salesforce’s first-quarter fiscal 2027 results showed revenue of $11.1 billion, up 13% year over year, while the company also raised the midpoint of its full-year revenue outlook to $45.9 billion to $46.2 billion.

The same quarterly release said current remaining performance obligation rose 14% year over year and noted Agentforce reached $1.2 billion in annual recurring revenue, showing traction but not fully easing concerns about the pace of broader growth reacceleration.

Recent analyst actions turned more cautious, with one firm removing its price target after citing weak customer feedback on Agentforce and another cutting its rating while pointing to a gap between AI momentum and subscription growth.

There does not appear to be a major fresh company-specific negative announcement today, so this could be because the market is still repricing Salesforce around uncertainty over how fast AI products can offset slower growth in more mature businesses.

Sources:

Salesforce Investor Relations, SEC, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CRM Insider Trading Activity

$CRM insiders have traded $CRM stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:

LAURA ALBER has made 2 purchases buying 2,571 shares for an estimated $500,266 and 0 sales.
DAVID BLAIR KIRK purchased 2,570 shares for an estimated $500,178

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CRM Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CRM Hedge Fund Activity

We have seen 1,030 institutional investors add shares of $CRM stock to their portfolio, and 1,787 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP removed 47,202,137 shares (-99.6%) from their portfolio in Q1 2026, for an estimated $8,797,534,294
MORGAN STANLEY added 12,666,457 shares (+66.6%) to their portfolio in Q1 2026, for an estimated $2,360,774,255
CAPITAL INTERNATIONAL INVESTORS removed 10,096,552 shares (-44.4%) from their portfolio in Q1 2026, for an estimated $1,881,795,361
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 7,160,302 shares (+130.2%) to their portfolio in Q1 2026, for an estimated $1,334,537,086
HARRIS ASSOCIATES L P added 5,126,665 shares (+52.4%) to their portfolio in Q1 2026, for an estimated $955,507,822
CAPITAL RESEARCH GLOBAL INVESTORS added 4,237,753 shares (+44.8%) to their portfolio in Q1 2026, for an estimated $789,832,404
INDEPENDENT FRANCHISE PARTNERS LLP added 3,497,051 shares (+650.0%) to their portfolio in Q1 2026, for an estimated $651,780,365

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CRM Congressional Stock Trading

Members of Congress have traded $CRM stock 6 times in the past 6 months. Of those trades, 4 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:

REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 2 purchases worth up to $100,000 on 06/02, 04/06 and 0 sales.
SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 1 purchase worth up to $15,000 on 02/09 and 2 sales worth up to $65,000 on 02/26.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CRM Analyst Ratings

Wall Street analysts have issued reports on $CRM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 02/26/2026

To track analyst ratings and price targets for $CRM, check out Quiver Quantitative's $CRM forecast page.

$CRM Price Targets

Multiple analysts have issued price targets for $CRM recently. We have seen 30 analysts offer price targets for $CRM in the last 6 months, with a median target of $240.0.

Here are some recent targets:

John Difucci from Guggenheim set a target price of $228.0 on 07/01/2026
David Hynes from Canaccord Genuity set a target price of $225.0 on 06/16/2026
Scott Berg from Needham set a target price of $400.0 on 06/16/2026
Derrick Wood from TD Cowen set a target price of $240.0 on 05/28/2026
Billy Fitzsimmons from Piper Sandler set a target price of $215.0 on 05/28/2026
Allan Verkhovski from BTIG set a target price of $255.0 on 05/28/2026
Jackson Ader from Keybanc set a target price of $290.0 on 05/28/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.